P408: Perspectives of rare disease experts on sequencing newborns for treatable genetic conditions*

• Nidhi Shah,
• Nina Gold,
• Sophia Adelson,
• Shardae Williams,
• Sarah Bick,
• Jessica Gold,
• Alanna Strong,
• Rebecca Ganetzky,
• Amy Roberts,
• Melissa Walker,
• Alexander Holtz,
• Vijay Sankaran,
• Ottavia Delmonte,
• Weizhen Tan,
• Ingrid Holm,
• Jay Thiagarajah,
• Junne Kamihara,
• Jason Comander,
• Emily Place,
• Janey Wiggs,
• Robert Green

Affiliations

Nidhi Shah

Dartmouth Health Children's, Lebanon, NH

Nina Gold

Massachusetts General Hospital for Children, Boston, MA

Sophia Adelson

Brigham and Women's Hospital, Boston, MA

Shardae Williams

Brigham and Women's Hospital, Boston, MA

Sarah Bick

Boston Children's Hospital, Boston, MA

Jessica Gold

Children's Hospital of Philadelphia, Philadelphia, PA

Alanna Strong

Children's Hospital of Philadelphia, Philadelphia, PA

Rebecca Ganetzky

Children's Hospital of Philadelphia, Philadelphia, PA

Amy Roberts

Boston Children's Hospital, Boston, MA

Melissa Walker

Massachusetts General Hospital for Children, Boston, MA

Alexander Holtz

Boston Children's Hospital, Boston, MA

Vijay Sankaran

Boston Children's Hospital, Boston, MA

Ottavia Delmonte

National Institutes of Health, Bethesda, MD

Weizhen Tan

Massachusetts General Hospital for Children, Boston, MA

Ingrid Holm

Boston Children's Hospital, Boston, MA

Jay Thiagarajah

Boston Children's Hospital, Boston, MA

Junne Kamihara

Dana Farber Cancer Institute, Boston, MA

Jason Comander

Mass Eye and Ear Institute, Boston, MA

Emily Place

Mass Eye and Ear Institute, Boston, MA

Janey Wiggs

Mass Eye and Ear Institute, Boston, MA

Robert Green

Brigham and Women's Hospital, Boston, MA